Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease

Movement Disorders

Volumn 26, Issue 2, 2011, Pages 355-357

  Benincasa, Dario ^a   Pellicano, Clelia ^a   Fanciulli, Alessandra ^a   Pontieri, Francesco E ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

ADJUVANT THERAPY; ADULT; AGED; CASE REPORT; COMPULSION; DEPRESSION; EATING DISORDER; FEMALE; FOLLOW UP; FOOD INTAKE; HAMILTON SCALE; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADULT; AGED; ANTIPARKINSON AGENTS; BUPROPION; COMPULSIVE BEHAVIOR; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; LEVODOPA; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 79952713884     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23395     Document Type: Letter

References (7)

1. Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 2009; 24: 1561-1570.
2. Sohtaoglu M, Demiray DY, Kenangil G, Ozekmecki S, Erginoz E. Long term follow-up of Parkinson's disease patients with impulse control disorders. Parkinsonism Relat Disord 2010; 16: 334-337.
3. Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon M, Juncos JL, Obeso JA, Bezard E. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesia to impulse control disorder. Lancet Neurol 2009; 8: 1140-1149.
4. Fenu S, Wardas J, Morelli M. Impulse control disorder and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease. Behav Pharmacol 2009; 20: 363-379.
5. Arias HR, Santamaria A, Ali SF. Pharmacological and neuroxicological actions mediated by bupropion and diethylpropion. Int Rev Neurobiol 2009; 88: 223-255.
6. Horne RL, Ferguson JM, Pope HG, Jr, et al. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988; 49: 262-266.
7. Robles GI, Singh-Franco D, Ghin HL. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations. Clin Ther 2008; 30: 800-812.